Press Releases

Stay up-to-date with the latest announcements from the SGC.

Explore our official press releases to stay updated on our major accomplishments and new partnerships. Want to be the first to know about the latest news from SGC?

 

Myeloma UK and the SGC announce open-access collaboration to discover new drug targets for myeloma.

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to discover and characterise novel drug targets for myeloma using structural biology and chemical proteomics.

In this first partnership of its kind in Europe, Myeloma UK and the…

Takeda renews partnership with Structural Genomics Consortium at MaRS Toronto with new investment of $7.5 million

OAKVILLE, ON, Dec. 4, 2015 /CNW/ - Takeda Pharmaceutical Company Limited (Takeda) today announced it has renewed its partnership with the Structural Genomics Consortium (SGC) to fund collective drug research aimed at bringing new, more effective medicines to patients faster.…

AbbVie renews commitment to Structural Genomics Consortium

MONTREAL, Nov. 18, 2015 /CNW/ - AbbVie today announced its continued commitment to the Structural Genomics Consortium (SGC) by providing a cash sponsorship of CDA$7.5 million towards open access research leading to the discovery of new medicines. Today`s announcement coincides…